Finance

Lists
CRVO:NASDAQ
CervoMed Inc
US$ २.२९
+०.८८%
(+०.०२०) 1D
US$ २.३१
+०.८७% (+०.०२०)
Pre-market
Closed: अक्टोबर १४, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRVO...
Open
US$ २.२२
High
US$ २.४१
Low
US$ २.१३
Mkt. cap
३.४६ करोड
Avg. vol.
२.५७ लाख
Volume
१.७६ हजार
52-wk high
US$ १०.००
52-wk low
US$ २.१३
EPS
-US$ ३.२१
Beta
-०.७५
Shares outstanding
१.५१ करोड
No. of employees
१५
Open
US$ २.२२
High
US$ २.४१
Low
US$ २.१३
Mkt. cap
३.४६ करोड
Avg. vol.
२.५७ लाख
Volume
१.७६ हजार
52-wk high
US$ १०.००
52-wk low
US$ २.१३
EPS
-US$ ३.२१
Beta
-०.७५
Shares outstanding
१.५१ करोड
No. of employees
१५
News stories
From web sources and news partners
TipRanks
TipRanks
·
१६ घण्टा पहिले
CervoMed Updates Investors with New Regulatory Presentation
About CervoMed Inc
CEO-
Employees१५
Founded१९९५
Headquartersबोस्टन, म्यासेचुसेट्स, संयुक्त राज्य अमेरिका
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to CRVO in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CRVO in the last 3 months.
Highest
Current US$ २.२९
US$ २५.०० (+९९१.७०%)
Average
US$ १५.५० (+५७६.८६%)
Lowest
US$ ७.०० (+२०५.६८%)
Analyst
Recommendation
Action
Price target
Projected
Date
Boobalan Pachaiyappan
Roth MKM
Buy
Maintained
US$ ७.००
+२०५.७%
10/13/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
US$ १८.००
+६८६%
10/13/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
US$ २५.००
+९९१.७%
10/05/2026
Boris Peaker
JonesTrading
Buy
Maintained
US$ १२.००
+४२४%
09/28/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
US$ २१.००
+८१७%
05/17/2026
Soumit Roy
JonesTrading
Buy
Maintained
US$ २०.००
+७७३.४%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
३.२३ लाख
८.७३ हजार
-
-
Cost of goods sold
६०.४० लाख
५८.३० लाख
५१.३५ लाख
४३.२२ लाख
Cost of revenue
६०.४० लाख
५८.३० लाख
५१.३५ लाख
४३.२२ लाख
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२३.२६ लाख
२५.१० लाख
२९.७५ लाख
२३.५७ लाख
Operating expense
२३.२६ लाख
२५.१० लाख
२९.७५ लाख
२३.५७ लाख
Total operating expenses
८३.६७ लाख
८३.४० लाख
८१.११ लाख
६६.७९ लाख
Operating income
-८०.४४ लाख
-८३.३२ लाख
-८१.११ लाख
-६६.७९ लाख
Other non operating income
-१.२३ हजार
३.२९ हजार
-१.०२ हजार
२.०० हजार
EBT including unusual items
-७७.२७ लाख
-८०.८७ लाख
-७९.६४ लाख
-६५.७२ लाख
EBT excluding unusual items
-७७.२७ लाख
-८०.८७ लाख
-७९.६४ लाख
-६५.७२ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-७७.२७ लाख
-८०.८७ लाख
-७९.६४ लाख
-६५.७२ लाख
Net profit margin
-२,३९५.३४%
-९२,६८०.३८%
-
-
Earnings per share
-०.८४
-०.८८
-०.८६
-०.६४
Interest and investment income
३.१९ लाख
२.४१ लाख
१.४७ लाख
१.०५ लाख
Interest expense
-
-
-
-
Net interest expenses
३.१९ लाख
२.४१ लाख
१.४७ लाख
१.०५ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू